Search

Narendra Vaish Phones & Addresses

  • Kirkland, WA
  • 1313 Williams St, Denver, CO 80218 (303) 320-6864
  • 1313 Williams St #503, Denver, CO 80218 (303) 320-6864
  • Boulder, CO
  • 221 Kelton St, Allston, MA 02134 (617) 738-7614
  • 47 Hatherly Rd, Brighton, MA 02135 (617) 779-0311
  • Chestnut Hill, MA
  • Kiona, WA
  • Cambridge, MA
  • 4927 Thunderbird Cir APT 25, Boulder, CO 80303 (303) 887-4715

Work

Company: Phaserx inc Jul 2011 Position: Consultant

Education

School / High School: LEEDS SCHOOL OF BUSINESS, UNIVERSITY OF COLORADO- Boulder, CO 2006 Specialities: MBA in Marketing and Finance

Skills

Leading High Performing Teams Biomedica...

Resumes

Resumes

Narendra Vaish Photo 1

Patent Attorney

View page
Location:
13014 northeast 137Th Pl, Kirkland, WA 98034
Industry:
Law Practice
Work:
Leber Ip Law
Patent Attorney

Ronald A Peterson Law Clinic Jan 2018 - May 2018
Legal Intern

Comotion at University of Washington May 2017 - Jul 2017
Patent Intern

Center For Infectious Disease Research Aug 2016 - Dec 2016
Legal Intern

Bio Ventures For Global Health May 2016 - Jul 2016
Legal Intern
Education:
Seattle University School of Law 2015 - 2018
Doctor of Jurisprudence, Doctorates, Law
University of Colorado Boulder 2003 - 2006
Master of Business Administration, Masters, Marketing, Project Management, Finance
Indian Institute of Technology, Kanpur 1989 - 1994
Doctorates, Doctor of Philosophy, Organic Chemistry
Lucknow University, Lucknow 1987 - 1989
Master of Science, Masters, Organic Chemistry
Skills:
Drug Discovery
Biotechnology
Biochemistry
Molecular Biology
Assay Development
Chemistry
Cancer
Protein Chemistry
Pharmaceutical Industry
Cell Biology
In Vitro
Genomics
In Vivo
Life Sciences
Immunology
Technology Transfer
R&D
Oncology
Lifesciences
Patents
Drug Delivery
Chromatography
Bioinformatics
Cell Culture
Hplc
Pharmacology
High Throughput Screening
Antibodies
Pcr
Elisa
Infectious Diseases
Drug Design
Western Blotting
Intellectual Property
Sirna
Toxicology
Formulation
Molecular Evolution
Therapeutics
Cell Based Assays
Diagnostics
Genetics
Rnai
Microarray Analysis
Flow Cytometry
Microarray
Immunoassays
Peptides
Rt Pcr
Dna Sequencing
Languages:
English
Hindi
Narendra Vaish Photo 2

Narendra Vaish

View page
Location:
Greater Denver Area
Industry:
Biotechnology
Narendra Vaish Photo 3

Narendra Vaish Kirkland, WA

View page
Work:
PhaseRx Inc

Jul 2011 to Apr 2012
Consultant

Marina Biotech Inc

Jan 2007 to Feb 2011
Associate Director

Sirna Therapeutics/Merck

Feb 2001 to Jan 2007
Scientist and Project Lead

Harvard Medical School and Boston College
Boston, MA
Aug 1998 to Jan 2001
Visiting Scientist and Research Associate

Max-Planck-Institute for Experimental Medicine

Sep 1995 to Jul 1998
Alexander von Humboldt Fellow and Max-Planck Fellow

Education:
LEEDS SCHOOL OF BUSINESS, UNIVERSITY OF COLORADO
Boulder, CO
2006
MBA in Marketing and Finance

Indian Institute of Technology
1994
Ph.D. in Peptide and Protein Sciences

Skills:
Leading High Performing Teams Biomedical Research Communication & Presentation Skills Drive for Results Global Mindset Integrity Attention to Detail
Narendra Vaish Photo 4

Narendra Vaish

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Narendra Vaish
Managing
Genomerx, LLC
Mfg Diagnostic Substances
13014 NE 137 Pl, Kirkland, WA 98034

Publications

Us Patents

Detection And Quantitation Of Nucleic Acid Molecules In Biological Samples

View page
US Patent:
7521184, Apr 21, 2009
Filed:
Aug 17, 2004
Appl. No.:
10/568134
Inventors:
Susan Radka - Arvada CO, US
Zinnen Shawn - Denver CO, US
Vasant Jadhav - Boulder CO, US
James McSwiggen - Boulder CO, US
Narendra Vaish - Denver CO, US
Assignee:
Sirna Therapeutics, Inc. - San Francisco CA
International Classification:
C12Q 1/68
C07H 21/02
C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
The present invention concerns processes for the detection and quantitation of nucleic acid molecules, polynucleotides, and/or oligonucleotides in a sample using hybridizationdetection assays, antibody-mediated recognition assays, nucleic acid sensor molecules, chromatographic assays, and/or electrophoresis assays. The present invention specifically concerns processes for the detection and quantitation of double stranded nucleic acid molecules, polynucleotides, and/or oligonucleotides in a sample using hybridization-detection assays. The nucleic acid molecules, polynucleotides, and/or oligonucleotides can include molecules that mediate RNA interference, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules. The nucleic acid molecules, polynucleotides, and/or oligonucleotides can include nucleic acid aptamers, enzymatic nucleic acid molecules, decoys, antisense, 2′,5′-oligoadenylate molecules, triplex forming oligonucleotides or any other nucleic acid molecule of interest. The present invention also concerns kits that allow for the detection and quantitation of nucleic acid molecules, polynucleotides, and/or oligonucleotides in a sample.

Nucleic Acid Sensor Molecules

View page
US Patent:
20020102568, Aug 1, 2002
Filed:
Jun 8, 2001
Appl. No.:
09/877526
Inventors:
Nassim Usman - Lafayette CO, US
James McSwiggen - Boulder CO, US
Shawn Zinnen - Denver CO, US
Scott Seiwert - Lyons CO, US
Peter Haeberli - Berthoud CO, US
Bharat Chowrira - Broomfield CO, US
Lawrence Blatt - Boulder CO, US
Narendra Vaish - Boulder CO, US
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 536/024300
Abstract:
Nucleic acid sensor molecules and methods are disclosed for the detection and amplification of signaling agents using enzymatic nucleic acid constructs, including hammerhead enzymatic nucleic acid molecules, inozymes, G-cleaver enzymatic nucleic acid molecules, zinzymes, amberzymes and DNAzymes; kits for detection and amplification; use in diagnostics, nucleic acid circuits, nucleic acid computers, therapeutics, target validation, target discovery, drug optimization, SNP detection, SNP scoring, proteome scoring and other uses are disclosed.

Nucleic Acid Sensor Molecules

View page
US Patent:
20030008295, Jan 9, 2003
Filed:
Nov 5, 2001
Appl. No.:
09/992160
Inventors:
Nassim Usman - Lafayette CO, US
James McSwiggen - Boulder CO, US
Shawn Zinnen - Denver CO, US
Scott Seiwert - Lyons CO, US
Peter Haeberli - Berthoud CO, US
Bharat Chowrira - Broomfield CO, US
Lawrence Blatt - Boulder CO, US
Narendra Vaish - Boulder CO, US
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 536/023100
Abstract:
Nucleic acid sensor molecules and methods are disclosed for the detection and amplification of signaling agents using enzymatic nucleic acid constructs, including hammerhead enzymatic nucleic acid molecules, inozymes, G-cleaver enzymatic nucleic acid molecules, zinzymes, amberzymes and DNAzymes; kits for detection and amplification; use in diagnostics, nucleic acid circuits, nucleic acid computers, therapeutics, target validation, target discovery, drug optimization, SNP detection, SNP scoring, proteome scoring and other uses are disclosed.

Nucleic Acid Sensor Molecules

View page
US Patent:
20030065155, Apr 3, 2003
Filed:
Jan 23, 2002
Appl. No.:
10/056761
Inventors:
Nassim Usman - Lafayette CO, US
James McSwiggen - Boulder CO, US
Shawn Zinnen - Denver CO, US
Scott Seiwert - Lyons CO, US
Peter Haeberli - Berthoud CO, US
Bharat Chowrira - Broomfield CO, US
Lawrence Blatt - Boulder CO, US
Narendra Vaish - Boulder CO, US
International Classification:
C07H021/02
C07H021/04
US Classification:
536/023100
Abstract:
Nucleic acid sensor molecules and methods are provided for the detection and amplification of signaling agents using enzymatic nucleic acid constructs, including hammerhead enzymatic nucleic acid molecules, inozymes, G-cleaver enzymatic nucleic acid molecules, zinzymes, amberzymes and DNAzymes. Also provided are kits for detection and amplification. The nucleic acid sensor molecules, methods and kits provided herein can be used in diagnostics, nucleic acid circuits, nucleic acid computers, therapeutics, target validation, target discovery, drug optimization, single nucleotide polymorphism (SNP) detection, single nucleotide polymorphism (SNP) scoring, and proteome scoring as well as other uses described herein.

Allosteric Nucleic Acid Sensor Molecules

View page
US Patent:
20040009510, Jan 15, 2004
Filed:
Apr 23, 2003
Appl. No.:
10/422050
Inventors:
Scott Seiwert - Pacifica CA, US
Narendra Vaish - Denver CO, US
Shawn Zinnen - Denver CO, US
Vasant Jadhav - Boulder CO, US
Karl Kossen - Westminster CO, US
International Classification:
C12Q001/68
C07H021/04
C12N009/22
US Classification:
435/006000, 435/199000, 536/024300
Abstract:
Nucleic acid sensor molecules and methods are provided for the detection and amplification of signaling agents using enzymatic nucleic acid constructs, including Halfzymes, multicomponent nucleic acid sensor molecules, hammerhead enzymatic nucleic acid molecules, inozymes, G-cleaver enzymatic nucleic acid molecules, zinzymes, amberzymes and DNAzymes. Also provided are kits for detection and amplification. The nucleic acid sensor molecules, methods and kits provided herein can be used in diagnostics, nucleic acid circuits, nucleic acid computers, therapeutics, target validation, target discovery, drug optimization, single nucleotide polymorphism (SNP) detection, single nucleotide polymorphism (SNP) scoring, and proteome scoring as well as other uses described herein.

Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)

View page
US Patent:
20040192626, Sep 30, 2004
Filed:
May 23, 2003
Appl. No.:
10/444853
Inventors:
James McSwiggen - Boulder CO, US
Bharat Chowrira - Louisville CO, US
Leonid Beigelman - Longmont CO, US
Dennis Macejak - Arvada CO, US
Shawn Zinnen - Denver CO, US
Pamela Pavco - Lafayette CO, US
Peter Haeberli - Berthoud CO, US
David Morrissey - Boulder CO, US
Kathy Fosnaugh - Boulder CO, US
Sharon Jamison - Boulder CO, US
Nassim Usman - Lafayette CO, US
James Thompson - Lafayette CO, US
Chandra Vargeese - Thorton CO, US
Weimin Wang - Superior CO, US
Tongqian Chen - Longmont CO, US
Narendra Vaish - Boulder CO, US
International Classification:
A61K048/00
C07H021/04
US Classification:
514/044000, 536/023100
Abstract:
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.

Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)

View page
US Patent:
20050020525, Jan 27, 2005
Filed:
Jan 14, 2004
Appl. No.:
10/757803
Inventors:
James McSwiggen - Boulder CO, US
Bharat Chowrira - Louisville CO, US
Leonid Beigelman - Longmont CO, US
Dennis Macejak - Arvada CO, US
Shawn Zinnen - Denver CO, US
Pamela Pavco - Lafayette CO, US
Peter Haeberli - Berthoud CO, US
David Morissey - Boulder CO, US
Kathy Fosnaugh - Boulder CO, US
Sharon Jamison - Boulder CO, US
Nassim Usman - Lafayette CO, US
James Thompson - Lafayette CO, US
Chandra Vargeese - Broomfield CO, US
Weimen Wang - Superior CO, US
Narendra Vaish - Longmont CO, US
International Classification:
A61K048/00
C07H021/02
US Classification:
514044000, 536023100
Abstract:
The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.

Rna Interference Mediated Inhibition 5-Alpha Reductase And Androgen Receptor Gene Expression Using Short Interfering Nucleic Acid (Sina)

View page
US Patent:
20050159376, Jul 21, 2005
Filed:
May 12, 2004
Appl. No.:
10/844072
Inventors:
James McSwiggen - Boulder CO, US
Narendra Vaish - Denver CO, US
Assignee:
Slrna Therapeutics, Inc. - Boulder CO
International Classification:
A61K048/00
C07H021/02
US Classification:
514044000, 536023100
Abstract:
This invention relates to compounds, compositions, and methods useful for modulating 5-alpha reductase (SRD5A-1, SRD5A-2) and androgen receptor (AR) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of 5-alpha reductase and androgen receptor (AR) gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (mRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of 5-alpha reductase and androgen receptor (AR) genes.
Narendra K Vaish from Kirkland, WA, age ~64 Get Report